Summary

Market Overview
The Global Forensic Genomics Market is expected to expand from USD 602.55 million in 2025 to USD 1439.43 million by 2031, reflecting a compound annual growth rate (CAGR) of 15.62%. This field utilizes genomic tools in legal and criminal inquiries to accurately identify individuals using DNA from crime scene evidence or human remains. Market expansion is largely fueled by rising global crime rates that necessitate sophisticated DNA profiling and identification methods. Additionally, the continuous evolution of DNA analysis tools and government efforts to create or enlarge national DNA databases heavily stimulate market demand. For example, the U.S. Department of Justice reported that by 2024, the CODIS database had produced over 20 million offender profiles, assisting in more than 600,000 cases. Even with these positive factors, the high financial investment needed for cutting-edge genomic technologies poses a major obstacle to market growth. The steep expenses tied to advanced machinery, specialized reagents, and intricate bioinformatics software act as a severe constraint for many forensic labs, especially in developing areas, which ultimately slows down wider market adoption and practical application.
Market Driver
Progress in DNA analysis and genomic technologies acts as a central catalyst propelling the global forensic genomics market forward. Ongoing breakthroughs in sequencing systems, bioinformatics, and DNA profiling allow forensic facilities to handle difficult samples, such as trace or degraded DNA, with heightened precision and sensitivity. These technological leaps also promote the use of sophisticated techniques like forensic genetic genealogy, broadening the investigative scope for previously unsolvable mysteries. As noted by WLRN, the Texas-based company Othram reported in April 2026 that its technology helped solve at least 600 cold cases across the country. Such advancements are vital for establishing kinship, identifying human remains, and connecting suspects to crime locations, ultimately strengthening law enforcement worldwide. At the same time, rising government support and financial backing for forensic science play a critical role in building the market's infrastructure and operational scale. Authorities around the world increasingly acknowledge the importance of advanced DNA testing for public safety and crime solving, prompting direct investments in specialized training, technology integration, and database growth. These efforts primarily aim to shrink forensic case backlogs and improve tools for intricate investigations. For instance, WLRN reported in April 2026 that the Florida Attorney General unveiled a $600,000 collaboration with a firm focused on linking cold case DNA to genetic genealogy networks. This financial dedication aids in procuring genomic hardware and fostering global partnerships. Additionally, Othram highlighted in December 2025 that a comprehensive review of 477 human remains cases in North America resulted in successful identifications, emphasizing the wide-ranging benefits of forensic genomics fueled by these investments.
Market Challenge
The massive financial investment needed for cutting-edge genomic technologies acts as a major roadblock to the growth of the global forensic genomics market. This hurdle includes the steep expenses tied to acquiring the intricate bioinformatics software, specialized reagents, and advanced machinery required for contemporary DNA testing. Such heavy financial burdens create a significant obstacle for many forensic facilities, especially those functioning on tight budgets or located in developing nations. Consequently, these high upfront costs directly impede the widespread acceptance and practical use of modern genomic practices. Facilities facing financial constraints frequently find it difficult to purchase necessary equipment and cover continuous operational costs, such as software licenses and daily consumables. This predicament limits their capacity to adopt new genomic methods or modernize their current systems, ultimately hindering broader market progress. To illustrate, the Consortium of Forensic Science Organizations (CFSO) noted in its July 2024 budget brief for Fiscal Year 2025 that the U.S. House of Representatives suggested a minimum of $2,000,000 for high-density sequencing out of the $6,000,000 designated for the National Missing and Unidentified Persons System (NamUs). This restricted funding underscores the budgetary constraints experienced by numerous regions, directly affecting the broad utilization of accurate genomic resources in legal and criminal inquiries.
Market Trends
The extensive implementation of Next-Generation Sequencing (NGS) in everyday casework is profoundly altering what forensic laboratories can achieve. This transition facilitates a more thorough and intricate genetic evaluation for regular criminal cases, surpassing older, lower-resolution techniques. NGS permits the concurrent examination of a vastly greater array of genetic markers, yielding deeper investigative insights even from difficult or trace DNA evidence. As an example, Syracuse University reported in June 2025 in 'Setting the Standard, Ensuring Justice' that the Kern Regional Crime Lab effectively employed NGS to assess more than 150 genetic markers from one murder investigation evidence sample, a massive leap from the roughly 24 markers identified by previous methods. At the same time, merging artificial intelligence (AI) with bioinformatics for automated data reading is becoming a prominent trend, helping labs manage the surging volume and intricacy of genomic information. Tools driven by AI simplify the tedious data analysis workflow, boost precision in separating DNA mixtures, and minimize the risk of human mistakes when deciphering complicated profiles. Such automation is essential for increasing laboratory productivity and speeding up the closure of cases. Highlighting this shift, Research.com noted in April 2026 through '2026 AI, Automation, and the Future of Forensic Science Degree Careers' that 35% of forensic science facilities in the United States have already started integrating AI-based technologies into their daily operations.

Key Market Players
* Illumina, Inc.
* Verogen, Inc.
* Agilent Technologies, Inc.
* Thermo Fischer Scientific, Inc.
* QIAGEN N.V.
* GE Healthcare
* Gene by Gene, Ltd.
* Neogen Corporation
* Eurofins Scientific SE
* Othram Inc.

Report Scope
In this report, the Global Forensic Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

# Forensic Genomics Market, By Component
* Kits
* Analyzers & Sequencers
* Software
* Consumables
# Forensic Genomics Market, By Technique
* Capillary Electrophoresis {CE}
* Next-generation Sequencing {NGS}
* PCR Amplification
# Forensic Genomics Market, By Application
* Criminal Testing
* Paternity & Familial Testing
* Biodefense
* Others
# Forensic Genomics Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Forensic Genomics Market.
Available Customizations:
Global Forensic Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Forensic Genomics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Kits, Analyzers & Sequencers, Software, Consumables)
5.2.2. By Technique (Capillary Electrophoresis {CE}, Next-generation Sequencing {NGS}, PCR Amplification)
5.2.3. By Application (Criminal Testing, Paternity & Familial Testing, Biodefense, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Forensic Genomics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Technique
6.2.3. By Application
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Forensic Genomics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Component
6.3.1.2.2. By Technique
6.3.1.2.3. By Application
6.3.2. Canada Forensic Genomics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Component
6.3.2.2.2. By Technique
6.3.2.2.3. By Application
6.3.3. Mexico Forensic Genomics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Component
6.3.3.2.2. By Technique
6.3.3.2.3. By Application
7. Europe Forensic Genomics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Technique
7.2.3. By Application
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Forensic Genomics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Component
7.3.1.2.2. By Technique
7.3.1.2.3. By Application
7.3.2. France Forensic Genomics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Component
7.3.2.2.2. By Technique
7.3.2.2.3. By Application
7.3.3. United Kingdom Forensic Genomics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Component
7.3.3.2.2. By Technique
7.3.3.2.3. By Application
7.3.4. Italy Forensic Genomics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Component
7.3.4.2.2. By Technique
7.3.4.2.3. By Application
7.3.5. Spain Forensic Genomics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Component
7.3.5.2.2. By Technique
7.3.5.2.3. By Application
8. Asia Pacific Forensic Genomics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Technique
8.2.3. By Application
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Forensic Genomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Technique
8.3.1.2.3. By Application
8.3.2. India Forensic Genomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Technique
8.3.2.2.3. By Application
8.3.3. Japan Forensic Genomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Technique
8.3.3.2.3. By Application
8.3.4. South Korea Forensic Genomics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Component
8.3.4.2.2. By Technique
8.3.4.2.3. By Application
8.3.5. Australia Forensic Genomics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Component
8.3.5.2.2. By Technique
8.3.5.2.3. By Application
9. Middle East & Africa Forensic Genomics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Technique
9.2.3. By Application
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Forensic Genomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Technique
9.3.1.2.3. By Application
9.3.2. UAE Forensic Genomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Technique
9.3.2.2.3. By Application
9.3.3. South Africa Forensic Genomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Technique
9.3.3.2.3. By Application
10. South America Forensic Genomics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Technique
10.2.3. By Application
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Forensic Genomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Technique
10.3.1.2.3. By Application
10.3.2. Colombia Forensic Genomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Technique
10.3.2.2.3. By Application
10.3.3. Argentina Forensic Genomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Technique
10.3.3.2.3. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Forensic Genomics Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Illumina, Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Verogen, Inc.
15.3. Agilent Technologies, Inc.
15.4. Thermo Fischer Scientific, Inc.
15.5. QIAGEN N.V.
15.6. GE Healthcare
15.7. Gene by Gene, Ltd.
15.8. Neogen Corporation
15.9. Eurofins Scientific SE
15.10. Othram Inc.
16. Strategic Recommendations
17. About Us & Disclaimer